TX-MOGAS-INDUSTRIES
18.5.2023 05:34:29 CEST | Business Wire | Press release
MOGAS Industries, Inc. (MOGAS) will be celebrating its 50-year anniversary with a commemorative celebration on Thursday, May 18th, 2023. The company officially began at 8:20 p.m. on May 17th, 1973.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230517005845/en/
Matt Mogas (left) and Louis Mogas (right) pose next to a large MOGAS ball valve (Photo: Business Wire)
MOGAS has earned a global reputation as a leading severe service manufacturer for the most extreme industrial applications in power, mining, refining, petrochemical/chemical, oil & gas, and specialty application industries. Significant business units include Severe Service Valves, Systems & Consulting (modules), Surface Technologies (coatings), Service & Reliability.
Louis Mogas formed Mogas Machine Works in 1973 with 16 employees working under 19,000 sq ft of manufacturing space on a couple of acres. Today, privately owned MOGAS Industries employs over 325 people across six countries. Their Houston-based headquarters now has 100,000 sq ft of manufacturing capacity spanning 15 acres. Campus improvements, such as 'Class A' corporate offices, an advanced coating facility, a 3-acre wooded park and numerous facility upgrades attest to MOGAS' success—not only as a significant manufacturer—but also to the Company staying true to its original business philosophy of putting people before profits.
A significant part of MOGAS sales is international, with sales and service centers in China, Australia, Canada, South America, Africa, The Middle East, Europe and India. With representatives and technicians in more than 40 countries, MOGAS is known for partnering with its customers to meet the ever-increasing challenges of severe-service applications.
On the occasion of the company’s 50th anniversary, MOGAS CEO/COO Matt Mogas notes: “I feel incredibly blessed to have worked with so many great employees, representatives, and customers these last 33 years. They have made a meaningful impact on MOGAS Industries and me personally. I feel honored to stand on the shoulders of the great men that came before me at MOGAS, especially Sam Furman, Tommy Bright, Cary Lorenz and of course my father, Louis Mogas, the grand architect, master, creator of our culture, beliefs and vision.”
Serving the community is ingrained in the MOGAS culture. The Company contributes significant resources to many worthy causes and enthusiastically supports their employees’ robust spirit of volunteerism. Charitable contributions to organizations include: Ronald McDonald House, MS150, Camp for All, The Periwinkle Foundation, and business partnerships with local elementary and junior schools. The Company also supports private initiatives for public good, focusing on quality of life.
The entire MOGAS organization is proud of this momentous achievement.
For more information, please contact MOGAS Industries at 281.449.0291 or Email: marketing@mogas.com
About MOGAS Industries, Inc.
MOGAS Industries Inc. is the most trusted severe service technology company, providing world-renowned services and the best severe service, application-specific products for critical applications in power, mining, oil & gas, refining, chemical/petrochemical and specialty industries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230517005845/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom